Physician profile
Jennifer E Ramirez
NPI 1023484201
$690.87
in general payments reported to CMS, 2019-2025
16 companies · $301 in 2025
The $301 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $20.24 · 2022: $88.62 · 2023: $160 · 2024: $121 · 2025: $301.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $582.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $582.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $120.73 | 2023-2025 | Rexulti |
| Abbvie INC. | $116.06 | 2022-2025 | |
| Idorsia Pharmaceuticals US INC | $70.15 | 2022-2025 | Quviviq, Quviviq |
| Teva Pharmaceuticals USA, INC. | $67.45 | 2023-2025 | Austedo Xr, Austedo Xr |
| Vanda Pharmaceuticals INC. | $50.77 | 2022-2025 | Fanapt |
| Brainsway USA INC | $38.59 | 2025 | Deep Tms System |
| Braeburn INC. | $37.84 | 2024 | Brixadi |
| Axsome Therapeutics, INC. | $33.30 | 2023 | Auvelity |
| Abiomed | $25.30 | 2023 | Impella |
| Alkermes, INC. | $24.77 | 2025 | Vivitrol |
| Sunovion Pharmaceuticals INC. | $24.16 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $20.88 | 2025 | Cobenfy |
| Neurocrine Biosciences, INC. | $20.24 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.03 | 2025 | Trintellix |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $14.62 | 2025 | Caplyta |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $10.98 | 2023 | Azstarys |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Ramirez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.